- £827.39m
- £960.99m
- £757.10m
- 78
- 65
- 53
- 77
Annual income statement for Bodycote, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 598 | 616 | 744 | 803 | 757 |
| Cost of Revenue | |||||
| Gross Profit | 192 | 235 | 270 | 302 | 297 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 593 | 532 | 642 | 683 | 719 |
| Operating Profit | 5 | 83.8 | 102 | 119 | 37.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -1.5 | 77.5 | 95.3 | 112 | 28.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.8 | 60 | 74.3 | 86.8 | 20.7 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.4 | 59.5 | 73.7 | 85.6 | 20 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.4 | 59.5 | 73.7 | 85.6 | 20 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.25 | 0.332 | 0.4 | 0.439 | 0.409 |
| Dividends per Share |